Sustained-Release Ashwagandha: Study Reports Potential for Physical Performance and Wellbeing in Active Adults

A 90-day clinical study conducted by Nutriventia indicates that a sustained-release ashwagandha ingredient may contribute to improvements in muscular strength, cardiorespiratory endurance (VO2 Max), and overall mental and physical wellbeing in active, healthy adults. This research extends the understanding of ashwagandha's potential efficacy, complementing its established role in stress reduction. The study's findings could inform new product development and support for claims within the sports nutrition and general wellness sectors, particularly for active populations seeking performance and quality of life benefits. ## Expanding Ashwagandha's Efficacy Profile Ashwagandha (Withania somnifera) is recognised as an adaptogenic botanical, primarily valued for its anxiolytic and stress-reducing properties. Previous research has linked ashwagandha supplementation to reductions in perceived stress, anxiety, and triglyceride levels in specific populations. It has also shown potential for improvements in strength and muscle size when combined with resistance training. This latest clinical trial focused on a sustained-release formulation, investigating its effects over a 90-day period. The study reported that supplementation was both well-tolerated and effective. The observed improvements in muscular strength and cardiorespiratory endurance (VO2 Max) suggest a benefit for physical performance, which may be relevant for sports nutrition and active lifestyle supplements. Furthermore, the study reported enhancements in participants' overall mental and physical wellbeing, suggesting a broader benefit that aligns with quality of life improvements. These findings position ashwagandha not solely as a stress-management aid but also as a multifaceted ingredient for active individuals. ## Market Implications for Product Development The supplement industry has increasingly incorporated ashwagandha into functional food and beverage applications, moving beyond traditional capsule or powder formats. This includes its presence in hot beverages, snacks, and dairy alternatives. This new research provides a scientific basis for potentially broadening the ingredient's application. Manufacturers and formulators may consider ashwagandha for products targeting athletic performance, recovery, and general vitality, in addition to its established use for stress and mood support. The sustained-release format itself may offer advantages in ingredient delivery and efficacy, potentially leading to differentiated product offerings. While the specific dosage and standardisation of ashwagandha used in the Nutriventia study, as well as the precise demographic characteristics of the 'active healthy adults', were not detailed in the provided information, the reported outcomes are notable. The research may provide a foundation for exploring new regulatory considerations and novel claims, particularly in regions with established health claim frameworks such as those overseen by EFSA or FDA, subject to further data and regulatory review. This development underscores ashwagandha's versatility and its growing potential as a key ingredient in the evolving landscape of functional ingredients for health and performance.